MRI findings of BOLD: A phase 2 dose-finding study using adaptive design and modeling methods for BAF312 in relapsing-remitting MS

Authors
Category Primary study
ConferenceNeurology
Year 2012
This article has no abstract
Epistemonikos ID: 41c2b571c9518d640535197c5c22dbe54044f5e7
First added on: Apr 30, 2026